$3.28 Million Awarded for ME/CFS Biomarker Study

Moving Toward a Genomic CBC for ME/CFS
There are two major barriers to identifying ME/CFS biomarkers: 1) variations in how patients are effected, in terms of symptoms and disease progression and 2) the lack of quantitative tools to specifically classify patients and examine the molecular immune underpinnings of the disease. Doctors use tests such as a complete blood count (CBC) to evaluate health and detect diseases by counting the blood cell types – too many or too few can indicate disease. In the case of ME/CFS the CBC is used to rule out other “medically explained” diseases rather than to detect it because in ME/CFS blood cell number doesn’t drastically change. What does change in ME/CFS is the function of blood cells important for the immune response; genomic tools applied to individual immune cells can detect what is causing the altered function. This is what we call the “genomic CBC”.
[pullquote align=”right” cite=”” link=”” color=”” class=”” size=””]“Our goal is to develop a detailed functional and genetic immunological framework that can be used to decode the mechanisms of ME/CFS and develop immune-biomarker sets for predicting disease susceptibility, stratifying patients and guiding treatment strategies.”  Dr. Unutmaz[/pullquote] A few years ago Suzanne D. Vernon, PhD was introduced to Professor Derya Unutmaz, M.D., renowned immunologist at the Jackson Laboratory for Genomic Medicine. His research focuses on defining the optimal immune response and what happens during infection and chronic disease. Dr. Vernon knew this was a very good fit for ME/CFS! Intrigued by what Vernon told him about ME/CFS, Unutmaz wanted to apply cutting-edge immunogenomics to blood samples from patients, so they worked together to generate some preliminary results on a small set of ME/CFS patients. This data was intriguing enough that Unutmaz applied to the NIH for funding to expand the numbers of patient samples and types of quantitative analyses on the blood.
The National Institute of Allergy and Infection Diseases (NIAID) of NIH recently funded Dr. Unutmaz’s grant application. He will receive five years of funding – totaling $3,281,515 from the National Institute of Allergy and Infectious Diseases — to find better ways to diagnose and treat ME/CFS. Dr. Lucinda Bateman and Suzanne D. Vernon, PhD are Co-Investigators on this project and the Bateman Horne Center will provide the required blood samples and correlating clinical information for the participating samples.
“We know that biomarkers will transform what we know about ME/CFS and how it can be treated. I believe we are well on our way to biomarkers to help guide more precise and personalized treatment for this disease!” says Vernon. Dr. Unutmaz hypothesizes that immune disturbances, particularly to the effector functions of T cell, natural killer and myeloid cell subsets, contribute to ME/CFS.
For too long, research in ME/CFS has been lean and under-funded for several reasons, including the shortage of accurately diagnosed patients available for research studies. The Bateman Horne Center – a clinic specializing in ME/CFS/FM and with a large number of patients who have been carefully and accurately diagnosed, and continue to be treated effectively – will partner with Dr. Unutmaz so that a Research Ready Army of well qualified patients can participate in this exciting research.
The Bateman Horne Center is committed to bringing ME/CFS and FM into the mainstream of clinical and medical science. Identifying biomarkers is a critical first step. BHC is a unique example of an independent non-profit integrative health center where medical care informs research, and research informs medical care. BHC is uniquely positioned to create collaborations between amazing, well-qualified patients and stellar research partners – an important component to progress.
LEARN MORE at www.BatemanHorneCenter.org

Facebook
Twitter
WhatsApp
Email

2 thoughts on “$3.28 Million Awarded for ME/CFS Biomarker Study”

  1. Five years? 5?
    This could be accomplished in 2-3 years and a replication study should be run at the same time because once the results are in no one will put much faith into it until it is replicated. So that will translate into 7-10 years before there is a test accepted by governments, medical systems, insurance, etc.
    If this disease killed on a regular basis, millions would be dead in a mere 7-10 years. Fortunately it is just a living death that destroys the hopes and dreams of the patient and caretakers and puts most into financial, medical and social peril.
    Move up the timeline and replicate this study using another clinic such as Nova South East or Stanford simultaneously.

  2. Its a great study but in terms of $$$
    Its a moonshot for cancer, and crapshoot for ME/CFS.
    Funding for zika is instantaneous………yet despite decades of neglect, we have to wait for ME/CFS studies to ramp up.

Comments are closed.

Latest News

Multiple pictures of people faces in red shirts behind a red overlay with a MEAction logo and the words #MillionsMissing Activism from Home in a gray box over the pictures.

#MillionsMissing 2022: Activism From Home Was Beyond Impressive

There has been so much happening since the #MillionsMissing protest on September 19th. We’ve shared some of our amazing press wins. You tuned into the live stream on Twitter. You saw the article that cover our government’s response. We are thrilled.  And we want to take a moment to acknowledge all of the amazing activism

Read More »
hand holding a paper sheet with injustice, unfairness symbol over crowded street background.

Tell HHS about your experience of healthcare discrimination

People with ME, Long COVID and other complex, chronic diseases have experienced all kinds of healthcare discrimination. Now there is an opportunity for you to share your story and urge our government to move forward with improved protections to secure access to healthcare that is free from discrimination or prejudice. The deadline to submit a

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top